Validation of Smart Garments for Gait Classification
Launched by MYANT MEDICAL CORP. · Jun 1, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
**Trial Summary: Validation of Smart Garments for Gait Classification**
This clinical trial is investigating the use of special smart garments made by Myant called SKIIN to assess how people walk and maintain their balance. The study aims to see if these garments can accurately measure gait and balance in healthy adults. To participate, individuals aged 18 to 64 who do not have any lower limb issues, neurological conditions, or a history of serious head injuries are invited to join.
If you decide to participate, you'll be asked to wear these smart garments while performing certain walking and balance tasks. The goal is to help researchers understand if these garments can be useful tools for measuring movement. This is an exciting opportunity to contribute to research that could lead to better ways to monitor gait and balance in various populations!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Healthy male and female adults aged 18y - 64y old
- Exclusion Criteria:
- • - Self-reported lower limb conditions, neurological disorders, history of concussion/brain trauma, and/or condition limiting exercise is to mitigate additional risk for injury and/or adverse reactions associated with exercise.
About Myant Medical Corp.
Myant Medical Corp. is a pioneering healthcare technology company dedicated to transforming the management of chronic diseases through innovative wearable solutions. By integrating advanced textile-based sensors with digital health platforms, Myant aims to provide real-time, actionable health insights that empower patients and healthcare providers alike. The company focuses on developing clinically validated products that enhance patient engagement and improve health outcomes, positioning itself at the forefront of the digital health revolution. With a commitment to research and collaboration, Myant Medical Corp. is actively engaged in clinical trials to validate and optimize its groundbreaking technologies for widespread clinical application.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Waterloo, Ontario, Canada
Patients applied
Trial Officials
James Tung, PhD
Principal Investigator
University of Waterloo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported